Stephen Asher
Neurology · Meridian, IDNPI 1871523373
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 56.0% of the total. Reporting peaked in 2019 at $8,518 and has fallen 88.3% since, to $995 in 2021.
Across 93 payments — averaging $104.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$5K
- Boston Scientific$1K
- Banner Life Sciences, LLC$900
- EMD Serono, Inc.$287
- Supernus Pharmaceuticals, Inc.$156
- Amneal Pharmaceuticals LLC$154
- plus $1K from 23 others
Across 12 payments — averaging $2087.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$25K
What the payments were for
- Speaking & faculty fees$5,34655%
- Travel & lodging$1,49815%
- Food & beverage$2,90230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $5,461 |
| Boston Scientific | 6 | $1,445 |
| Banner Life Sciences, LLC | 1 | $900 |
| EMD Serono, Inc. | 10 | $287 |
| Supernus Pharmaceuticals, Inc. | 14 | $156 |
| Amneal Pharmaceuticals LLC | 3 | $154 |
| AstraZeneca | 2 | $143 |
| Lilly USA, LLC | 4 | $135 |
| Novartis | 8 | $132 |
| Acorda Therapeutics, Inc | 6 | $123 |
| Kyowa Kirin, Inc. | 1 | $113 |
| Medtronic | 1 | $111 |
| AbbVie(2 entities) | 5 | $96 |
| Insightec,inc | 1 | $84 |
| Greenwich Biosciences, Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 3 | $39 |
| Sanofi | 2 | $37 |
| Amgen | 1 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Biogen | 2 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| Livanova USA, Inc. | 1 | $24 |
| CSL Behring | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Bristol Myers Squibb | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Saol Therapeutics Inc. | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,746 in reported general payments places this provider in the 80th percentile of 59 neurology providers in Idaho.
Other neurology in Meridian
- Kylie AbeMeridian$16K
- James HerroldMeridian$6K
- Anna IrwinMeridian$3K
- Martha ClineMeridian$3K
- Heidi OrmeMeridian$2K
- Stephen IrelandMeridian$1K
- Jozef OttowiczMeridian$107
- Dax SirucekMeridian$93
- Allen HanMeridian$60
- Bradford TalcottIdaho Falls$252K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.